SABS ▲ +0.3% - SAB Biotherapeutics, Inc. $SABS SABSW - SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress 01-OCT-2026 08:30 AM ET